Anthera Pharma (ANTH) Tops Q4 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. NVDA
2. PCVX
3. PTC
4. MSFT
5. SPY
6. META
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to Anthera Pharma (ANTH) Tops Q4 EPS by 10c

Piper Jaffray Cuts Price Target on Anthera Pharma (ANTH) to $10 Following 4Q

March 11, 2016 8:31 AM EST

Piper Jaffray maintained an Overweight rating on Anthera Pharma (NASDAQ: ANTH), and cut the price target to $10.00 (from $14.00), following the company's 4Q. Anthera stopped enrollment of the Phase II BRIGHT-SC trial of blisibimod at 57 IgA Nephropathy patients, of which 45 remained on study. Also, Anthera... More